- Benchmark ASINB0GYDZY21C
- MarketplaceUS
- Category ID3760941
- Analyzed Products
- Keywordhome health products
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥27.10estimated
- Data Date2026-07-27
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，已经是高风险价格战区，新品牌几乎没有真实成功样本。 目前可见的新品牌只有2个，新增产品3个，盈利率是0%，而且近12个月新上架产品里没有一款达到你要求的15%+稳定可接受水平；更关键的是，利润表现最好的样本也只是个别高毛利点位，不能代表可复制机会。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing不能进入。这个市场对新卖家和小商家都不友好，当前样本显示盈利率为0%，新品盈利率也为0%，而且没有任何可复制的真实小商家成功案例。 用户预算是50万人民币，表面上足以覆盖部分单品前期投入，但这个市场的核心问题不是“钱够不够”，而是“投进去也很难赚回去”。
证据很直接：Spalding 的两个新上架产品都没跑通，B0FQL56V2G 标价18.24美元、毛利率只有4.73%，B0FQKVLYGB 标价12.96美元、毛利率9.89%，都低于可接受的15%门槛；VKYOZVA 的单品 B0GYDZY21C 虽然毛利率看起来有36.27%，但品牌整体新产品盈利率是0%，说明只是个别样本，不能代表可复制成功。 竞争上，这个类目里新品牌新品盈利率为0%，新品牌新品非盈利率达到100%，说明新进入者几乎全军覆没；同时这些产品外观和功能都很常规，差异化弱，属于典型“同质化+价格压榨”环境。更重要的是，Spalding 属于老品牌背景，却把两个新产品都打成非盈利；这意味着老品牌也没占到便宜，市场并不是靠品牌名就能轻松吃下的。
结论：不建议推进。 50万人民币最多只能算“勉强够启动”，但不足以抵消这个市场的低胜率和低利润结构；对大品牌来说也不是好入口，因为没有明显高回报的benchmark ASIN。若一定要看样本，只能把 VKYOZVA 的 B0GYDZY21C 当作高毛利但高风险样本参考；小商家没有真正合格的成功样本可跟，Spalding 的 B0FQKVLYGB 和 B0FQL56V2G 都应视为失败案例而不是模板。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):0.00%Potential certificate expensesUL CertificationSome categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternatives- 一次性冷敷袋/瞬冷冰袋：无需加热，价格更低，适合临时肿胀、扭伤和运动后冷敷；缺点是不可重复使用，但对“先应急再决定是否长期购买”的用户很友好。
- 可重复使用的基础冰袋/热水袋：没有护具式压缩结构，但更便宜、获取更容易，家庭里多部位通用，适合想先用最小成本做冷热敷的人。
- 弹力护腕/护膝 + 独立冷敷包：分开买通常比一体式冷热护具更灵活，也更容易按尺寸选择；用户可以只买需要的部位版本，降低试错成本。
- 凝胶冷敷贴/退热贴式冷却贴：上手最简单，直接贴敷即可，适合轻度不适或短时缓解；虽然不如专业护具耐用，但更方便、门槛更低。
- 自发热护具/磁疗贴这类低价替代：如果用户主要诉求是保暖和舒缓，而非严格冷热切换，这类产品通常更便宜、更容易买到，也不用反复冷冻或微波。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，结论很明确：新品牌成功率为0%，而且所有可识别的新上架产品都是非盈利；同时市场没有形成可复制的真实小商家成功样本，反而更像是大牌/新入场品牌都在亏。 现有数据里，VKYOZVA 的 B0GYDZY21C 虽然标价 $45.16、毛利率看起来有 36.3%，但只卖到月销 50、近月收入约 $2,258，早期投入却高达 $4,560.26，且被判定为 INACTIVE_SALES，说明“高毛利不等于能跑通”。
证据很直接：市场可见的新品牌样本里，新品牌新品盈利率是 0%，新品牌新品失败率是 100%；按整体看，可识别利润产品占比 0.00%，新发布产品盈利占比 0.00%。时间趋势也不好看：2025 年和 2026 年出现的新发布里，能看到的都是非盈利，2025 年有 2 个 Spalding 新品失败，2026 年有 1 个 VKYOZVA 新品失败，说明不是“少量试错”，而是持续性地在打亏损仗。Spalding 的两个样本 B0FQL56V2G（$18.24，利润率 4.73%）和 B0FQKVLYGB（$12.96，利润率 9.89%）都低于 10% 这条线，已经落入价格战区；而且 5 个月内只有 4~5 条评论，不能算真实稳健成功，更像是靠激进推广在硬推。
New products with Highest revenueVKYOZVA
Recent Monthly Revenue (USD):$2,258.00(50pcs/month)B0GYDZY21C (4.5/5 (22 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQMost investment in new productsLeast profitable new productsLeast investment in new productsSpalding
Recent Monthly Revenue (USD):-(-)B0FQL56V2G (4.5/5 (5 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0FQKVLYGB (3.8/5 (4 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0FQL56V2G (4.5/5 (5 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FQKVLYGB (3.8/5 (4 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入，结论很明确：已处于价格战/早期饱和风险区，且新品牌没有任何真实成功样本。 现有数据里，新品牌新上架产品盈利率为0%，近一年所有新发布产品都是非盈利；同时当前可见的3个样本里，利润率只有0%~10%和36.3%，没有任何一款达到你要求的“新进入可接受”的15%+稳定水平。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0GYDZY21CVKYOZVA2026-06-16No$45.1650pcs$2258.036.27%$818.98B0FQL56V2GSpalding2025-09-10No$18.24-pcs$-4.73%$-B0FQKVLYGBSpalding2025-09-10No$12.96-pcs$-9.89%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0GYDZY21CVKYOZVA2026-06-16No$45.1650pcs$2258.036.27%$818.98B0FQL56V2GSpalding2025-09-10No$18.24-pcs$-4.73%$-B0FQKVLYGBSpalding2025-09-10No$12.96-pcs$-9.89%$-#New Product Success Rates
Listing这个市场不适合进入，已经接近价格战/低差异化的高风险区：样本里新上架产品成功率是0%，而且3个新上架样本全部不盈利；现有赢家也没有给新人留出可复制的低门槛路径。对大品牌来说可以砸钱试，但回报不确定；对小品牌来说，合法做法几乎看不到可行窗口。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
SpaldingVKYOZVA#Success Rate by Entry Time
Listing这个市场不值得进入，已经明显过热且接近/进入价格战区。 近期新品牌进入后几乎全军覆没，新增品牌的成功率为0%，而最近可见的新品利润也几乎全部低于10%，对大品牌和小商家都不是好市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 2 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 2 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 1 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases